Health Care › Biological Products (No Diagnostic Substances)

Seneca Biopharma (SNCA) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with SNCA stock chart to see long term trends.

SNCA stock compared to

SNCA Income Statement

Revenue, Net:

Revenue Per Share:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Net Income:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

SNCA Cash Flow

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Financing Activities:

Net Change in Cash & Equivalents:

SNCA Balance Sheet

Cash and Cash Equivalents:

Accounts Receivable, Net:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Total Short-Term Liabilities:

Total Liabilities:

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Sabby Management, LLC

393,411 sh

278,410 sh
242%

$229

$146

Renaissance Technologies LLC

260,818 sh

-183,805 sh
-41%

$152

-$168

Virtu Financial LLC

28,544 sh

-3,025 sh
-10%

$17

-$6

Blackrock Inc.

3,509 sh

Morgan Stanley

56 sh

Bank Of America Corp /De/

27 sh

6 sh
29%

Royal Bank Of Canada

4 sh

4 sh
NEW

Northern Trust Corp

0 sh

-11,961 sh
-100%

-$9

Proequities, Inc.

0 sh

Data imported from Seneca Biopharma, Inc. SEC filings. Check original filings before making any investment decision.